Rhabdomyolysis related to statin and seizures: report of 3 cases.
- Author:
Yu-qing GUAN
1
;
Yan-jie SHI
;
Qun WANG
Author Information
- Publication Type:Case Reports
- MeSH: Cerebral Infarction; drug therapy; Creatine Kinase; blood; Epilepsy; complications; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; adverse effects; therapeutic use; Lovastatin; adverse effects; therapeutic use; Male; Middle Aged; Rhabdomyolysis; chemically induced; enzymology; etiology; Simvastatin; adverse effects; therapeutic use
- From: Journal of Southern Medical University 2011;31(10):1795-1796
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the clinical features and prognosis of rhabdomyolysis related to seizure attacks and use of statin.
METHODSThe medical records of 3 patients with established diagnosis of rhabdomyolysis were analyzed and the related literatures were reviewed.
RESULTSAll the 3 patients had seizure attacks and/or used statin before the onset of rhabdomyolysis. Two of the patients complained of back pain, and all the 3 patients had dark-colored urine. Serum levels of creatine kinase (CK) were markedly increased by over 50 times above the normal upper limit. CK level kept increasing even after proper interventions, till reaching the peak level about 3 days later. The patients improved rapidly with full recovery thereafter, and CK became normal in 2 weeks. None of the patients had renal failure.
CONCLUSIONSeizure attacks and use of statin are common risk factors for non-traumatic rhabdomyolysis. Caution needs to be taken when prescribing statin to patients with recent seizure attacks. Special attention should be given to such early symptoms as muscle pain, weakness and dark-colored urine, and CK level monitoring is advisable in such cases.